Aarey Drugs & Pharmaceuticals Ltd. Announces Q3 Results for 2025 with No Depreciation Charged on New Fixed Assets

Aarey Drugs & Pharmaceuticals Ltd. has announced its unaudited financial results for the quarter ended 31st December, 2025. The company's revenue from operations stands at Rs. 9,642.63 Lakhs, with a total income of Rs. 13,306.86 Lakhs. The total expenses for the quarter are Rs. 12,376.17 Lakhs, resulting in a profit before exceptional items and tax of Rs. 960.69 Lakhs. The company has purchased new fixed assets during the reporting period, but they are not yet ready for use, hence no depreciation has been charged. The company operates in one segment, manufacturing and trading of drugs & pharmaceuticals and allied activities. The figures of the previous year have been regrouped wherever necessary.